{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:33:25Z","timestamp":1790973205365,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":4967,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.exphem.2008.05.006","type":"journal-article","created":{"date-parts":[[2008,8,24]],"date-time":"2008-08-24T04:28:22Z","timestamp":1219552102000},"page":"1480-1486.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Phenotypic variability within the JAK2 V617F-positive MPD: Roles of progenitor cell and neutrophil allele burdens"],"prefix":"10.1016","volume":"36","author":[{"given":"Alison R.","family":"Moliterno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ophelia","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry L.","family":"Spivak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2008.05.006_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM197610212951702","article-title":"Polycythemia vera: stem-cell and probable clonal origin of the disease","volume":"295","author":"Adamson","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2008.05.006_bib2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1046\/j.1365-2141.2002.03763.x","article-title":"Exploring polycythaemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detected","volume":"119","author":"Najfeld","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2008.05.006_bib3","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJM197406132902419","article-title":"Letter: bone-marrow responses in polycythemia vera","volume":"290","author":"Prchal","year":"1974","journal-title":"N Engl J Med"},{"issue":"9464","key":"10.1016\/j.exphem.2008.05.006_bib4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2008.05.006_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"issue":"7037","key":"10.1016\/j.exphem.2008.05.006_bib6","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2008.05.006_bib7","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI109989","article-title":"Polycythemia vera. Further in vitro studies of hematopoietic regulation","volume":"66","author":"Adamson","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2008.05.006_bib8","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood-2006-10-054940","article-title":"The JAK2 V617F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera","volume":"110","author":"Dupont","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.006_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/518809","article-title":"Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of Affymetrix single-nucleotide-polymorphism genotyping microarrays","volume":"81","author":"Yamamoto","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.exphem.2008.05.006_bib10","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1182\/blood-2006-04-018259","article-title":"Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia","volume":"108","author":"Scott","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.006_bib11","first-page":"132","article-title":"Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols","volume":"23","author":"Berk","year":"1986","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2008.05.006_bib12","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.leukres.2006.12.002","volume":"31","author":"Mesa","year":"2007","journal-title":"Leuk Res."},{"key":"10.1016\/j.exphem.2008.05.006_bib13","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1200\/JCO.1999.17.9.2954","article-title":"Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines","volume":"17","author":"Barosi","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2008.05.006_bib14","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/blood-2006-03-008805","article-title":"Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression","volume":"108","author":"Moliterno","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.006_bib15","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1182\/blood.V98.12.3249","article-title":"Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia","volume":"98","author":"Barosi","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.006_bib16","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood-2006-12-064287","article-title":"Clinical profile of homozygous JAK2V617F mutation in patients with polycythemia vera or essential thrombocythemia","volume":"110","author":"Vannucchi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.006_bib17","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood-2005-09-3826","article-title":"Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders","volume":"107","author":"Passamonti","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.006_bib18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1600-0609.2007.00960.x","article-title":"The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis\u2014impact on disease phenotype","volume":"79","author":"Larsen","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.exphem.2008.05.006_bib19","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1172\/JCI109003","article-title":"Polycythemia vera. The in vitro response of normal and abnormal stem cell lines to erythropoietin","volume":"61","author":"Prchal","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2008.05.006_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7326\/0003-4819-95-1-71","article-title":"Polycythemia: mechanisms and management","volume":"95","author":"Golde","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.exphem.2008.05.006_bib21","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1182\/blood-2006-04-017392","article-title":"Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia vera","volume":"108","author":"Ishii","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.006_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1980.tb01201.x","article-title":"Polycythaemia vera: in vitro studies of circulating erythroid progenitors","volume":"44","author":"Lacombe","year":"1980","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2008.05.006_bib23","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.006_bib24","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","article-title":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders","volume":"106","author":"Jones","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.006_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000101707","article-title":"Chronic myeloproliferative disorders: the role of tyrosine kinases in pathogenesis, diagnosis and therapy","volume":"74","author":"Macdonald","year":"2007","journal-title":"Pathobiology"},{"key":"10.1016\/j.exphem.2008.05.006_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2141.1995.tb03391.x","article-title":"Clonal analysis of haemopoietic cells in essential thrombocythaemia","volume":"90","author":"El Kassar","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2008.05.006_bib27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/(SICI)1096-8652(199902)60:2<158::AID-AJH14>3.0.CO;2-9","article-title":"Heterogeneity of clonal development in chronic myeloproliferative disorders","volume":"60","author":"Ferraris","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2008.05.006_bib28","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1073\/pnas.88.15.6848","article-title":"Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction","volume":"88","author":"Gilliland","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2008.05.006_bib29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood.V89.1.128","article-title":"Clonality analysis of hematopoiesis in essential thrombocythemia: advantages of studying T\u00a0lymphocytes and platelets","volume":"89","author":"El-Kassar","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.006_bib30","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/sj.leu.2404214","article-title":"Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disorders","volume":"20","author":"Kiladjian","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2008.05.006_bib31","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/sj.leu.2404755","article-title":"The quantitative JAK2 V617F neutrophil allele burden does not correlate with thrombotic risk in essential thrombocytosis","volume":"21","author":"Pemmaraju","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2008.05.006_bib32","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2006-02-002030","article-title":"JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis","volume":"108","author":"Lacout","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.006_bib33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0092-8674(00)81167-8","article-title":"Jak2 is essential for signaling through a variety of cytokine receptors","volume":"93","author":"Parganas","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2008.05.006_bib34","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood.V52.6.1196.1196","article-title":"Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera","volume":"52","author":"Eaves","year":"1978","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.006_bib35","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.exphem.2007.01.053","article-title":"V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules","volume":"35","author":"Falanga","year":"2007","journal-title":"Exp Hematol"},{"issue":"9501","key":"10.1016\/j.exphem.2008.05.006_bib36","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0140-6736(05)67785-9","article-title":"Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study","volume":"366","author":"Campbell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2008.05.006_bib37","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V90.9.3370","article-title":"Treatment of polycythemia vera: the use of hydroxyurea and pipobroman in 292 patients under the age of 65 years","volume":"90","author":"Najean","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.006_bib38","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1182\/blood-2006-05-025544","article-title":"Management of extreme thrombocytosis in otherwise low-risk essential thrombocythemia; does number matter?","volume":"108","author":"Tefferi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.006_bib39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM198102193040801","article-title":"Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy","volume":"304","author":"Berk","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2008.05.006_bib40","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1182\/blood.V32.4.536.536","article-title":"A study of hematological complications occurring in patients with polycythemia vera treated with 32-P (based on a series of 296 patients)","volume":"32","author":"Tubiana","year":"1968","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.05.006_bib41","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-123-9-199511010-00003","article-title":"Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia","volume":"123","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.exphem.2008.05.006_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.annepidem.2005.06.052","article-title":"Platelet counts differ by sex, ethnicity, and age in the United States","volume":"16","author":"Segal","year":"2006","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.exphem.2008.05.006_bib43","doi-asserted-by":"crossref","first-page":"11444","DOI":"10.1073\/pnas.0404241101","article-title":"Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis","volume":"101","author":"Moliterno","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2008.05.006_bib44","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1172\/JCI113549","article-title":"Transient suppression of clonal hemopoiesis associated with pregnancy in a patient with a myeloproliferative disorder","volume":"81","author":"Turhan","year":"1988","journal-title":"J\u00a0Clin Invest"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X08002282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X08002282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:26:42Z","timestamp":1759566402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X08002282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0301472X08002282"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2008.05.006","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic variability within the JAK2 V617F-positive MPD: Roles of progenitor cell and neutrophil allele burdens","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2008.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}